Cargando…
Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Copernicus GmbH
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517665/ https://www.ncbi.nlm.nih.gov/pubmed/32983844 http://dx.doi.org/10.5194/jbji-6-19-2020 |
| _version_ | 1783587269776506880 |
|---|---|
| author | Becker, Agathe Kreitmann, Louis Ferry, Tristan |
| author_facet | Becker, Agathe Kreitmann, Louis Ferry, Tristan |
| author_sort | Becker, Agathe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7517665 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Copernicus GmbH |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75176652020-09-25 Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) Becker, Agathe Kreitmann, Louis Ferry, Tristan J Bone Jt Infect Letter Copernicus GmbH 2020-07-22 /pmc/articles/PMC7517665/ /pubmed/32983844 http://dx.doi.org/10.5194/jbji-6-19-2020 Text en Copyright: © 2020 Agathe Becker et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter Becker, Agathe Kreitmann, Louis Ferry, Tristan Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) |
| title | Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) |
| title_full | Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) |
| title_fullStr | Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) |
| title_full_unstemmed | Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) |
| title_short | Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020) |
| title_sort | reply to scheper and de boer's comment on “duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to staphylococcus treated with a debridement, antibiotics and implant retention (dair): a retrospective multicenter study in france” by becker et al. (2020) |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517665/ https://www.ncbi.nlm.nih.gov/pubmed/32983844 http://dx.doi.org/10.5194/jbji-6-19-2020 |
| work_keys_str_mv | AT beckeragathe replytoscheperanddeboerscommentondurationofrifampintherapyisakeydeterminantofimprovedoutcomesinearlyonsetacuteprostheticjointinfectionduetostaphylococcustreatedwithadebridementantibioticsandimplantretentiondairaretrospectivemulticenterstudyinfrancebybecke AT kreitmannlouis replytoscheperanddeboerscommentondurationofrifampintherapyisakeydeterminantofimprovedoutcomesinearlyonsetacuteprostheticjointinfectionduetostaphylococcustreatedwithadebridementantibioticsandimplantretentiondairaretrospectivemulticenterstudyinfrancebybecke AT ferrytristan replytoscheperanddeboerscommentondurationofrifampintherapyisakeydeterminantofimprovedoutcomesinearlyonsetacuteprostheticjointinfectionduetostaphylococcustreatedwithadebridementantibioticsandimplantretentiondairaretrospectivemulticenterstudyinfrancebybecke |